MedTrace Logo

Metformin and Sitagliptin in Women With Previous Gestational Diabetes

NCT01336322 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-03-25

No results posted yet for this study

Summary

The goal of the present research is to compare the effects of treatment with metformin and sitagliptin, alone or in association, in women with previous gestational diabetes to evaluate the impact of the two drugs on beta-cell function. The study results may contribute to give a rational approach for future investigations.

Conditions

  • Pre-diabetes

Interventions

DRUG

Metformin

Metformin 850 mg bid

DRUG

Sitagliptin

Sitagliptin 100 mg qd

DRUG

Sitagliptin + Metformin

sitagliptin 100mg + metformin 850mg

Sponsors & Collaborators

Principal Investigators

  • Stefano Del Prato, MD · University of Pisa

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2017-12-31
Completion
2018-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01336322 on ClinicalTrials.gov